Annual Revenue
$4.42 M
-$50.92 M-92.02%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual revenue is $4.42 million, with the most recent change of -$50.92 million (-92.02%) on December 31, 2023.
- During the last 3 years, NGM annual revenue has fallen by -$82.95 million (-94.94%).
Performance
NGM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
$165.00 K
-$417.00 K-71.65%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly revenue is $165.00 thousand, with the most recent change of -$417.00 thousand (-71.65%) on December 31, 2023.
- Over the past year, NGM quarterly revenue has dropped by -$2.08 million (-92.66%).
Performance
NGM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$4.42 M
-$18.02 M-80.31%
December 31, 2023
Summary
- As of February 10, 2025, NGM TTM revenue is $4.42 million, with the most recent change of -$18.02 million (-80.31%) on December 31, 2023.
- Over the past year, NGM TTM revenue has dropped by -$32.22 million (-87.94%).
Performance
NGM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
NGM Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.0% | -92.7% | -87.9% |
| 3 y3 years | -94.9% | -99.2% | -94.9% |
| 5 y5 years | -95.9% | -99.7% | -95.7% |
NGM Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.3% | at low | -99.2% | at low | -94.3% | at low |
| 5 y | 5-year | -95.7% | at low | -99.5% | at low | -95.7% | at low |
| alltime | all time | -95.9% | at low | -99.6% | at low | -96.3% | at low |
NGM Biopharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $4.42 M(-92.0%) | $165.00 K(-71.6%) | $4.42 M(-80.3%) |
| Sep 2023 | - | $582.00 K(-59.1%) | $22.43 M(-24.6%) |
| Jun 2023 | - | $1.42 M(-36.7%) | $29.76 M(-18.8%) |
| Mar 2023 | - | $2.25 M(-87.6%) | $36.63 M(-33.8%) |
| Dec 2022 | $55.33 M(-29.0%) | $18.18 M(+129.8%) | $55.33 M(-4.8%) |
| Sep 2022 | - | $7.91 M(-4.6%) | $58.11 M(-15.5%) |
| Jun 2022 | - | $8.29 M(-60.4%) | $68.78 M(-11.0%) |
| Mar 2022 | - | $20.95 M(-0.1%) | $77.25 M(-0.8%) |
| Dec 2021 | $77.88 M(-10.9%) | $20.96 M(+12.8%) | $77.88 M(+1.6%) |
| Sep 2021 | - | $18.57 M(+10.7%) | $76.69 M(-6.0%) |
| Jun 2021 | - | $16.77 M(-22.3%) | $81.60 M(-3.5%) |
| Mar 2021 | - | $21.57 M(+9.1%) | $84.58 M(-3.2%) |
| Dec 2020 | $87.37 M | $19.77 M(-15.8%) | $87.37 M(-11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $23.48 M(+18.9%) | $98.68 M(+2.0%) |
| Jun 2020 | - | $19.75 M(-18.9%) | $96.77 M(-5.5%) |
| Mar 2020 | - | $24.36 M(-21.6%) | $102.36 M(-1.1%) |
| Dec 2019 | $103.54 M(-4.7%) | $31.08 M(+44.1%) | $103.54 M(-13.4%) |
| Sep 2019 | - | $21.57 M(-14.9%) | $119.58 M(+0.6%) |
| Jun 2019 | - | $25.34 M(-0.8%) | $118.83 M(+2.8%) |
| Mar 2019 | - | $25.55 M(-45.8%) | $115.60 M(+6.4%) |
| Dec 2018 | $108.67 M(+40.9%) | $47.12 M(+126.4%) | $108.67 M(+76.6%) |
| Sep 2018 | - | $20.82 M(-5.9%) | $61.55 M(+51.1%) |
| Jun 2018 | - | $22.12 M(+18.8%) | $40.73 M(+118.8%) |
| Mar 2018 | - | $18.61 M | $18.61 M |
| Dec 2017 | $77.14 M(-9.9%) | - | - |
| Dec 2016 | $85.59 M | - | - |
FAQ
- What is NGM Biopharmaceuticals annual revenue?
- What is the all time high annual revenue for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual revenue year-on-year change?
- What is NGM Biopharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly revenue year-on-year change?
- What is NGM Biopharmaceuticals TTM revenue?
- What is the all time high TTM revenue for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals TTM revenue year-on-year change?
What is NGM Biopharmaceuticals annual revenue?
The current annual revenue of NGM is $4.42 M
What is the all time high annual revenue for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual revenue is $108.67 M
What is NGM Biopharmaceuticals annual revenue year-on-year change?
Over the past year, NGM annual revenue has changed by -$50.92 M (-92.02%)
What is NGM Biopharmaceuticals quarterly revenue?
The current quarterly revenue of NGM is $165.00 K
What is the all time high quarterly revenue for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly revenue is $47.12 M
What is NGM Biopharmaceuticals quarterly revenue year-on-year change?
Over the past year, NGM quarterly revenue has changed by -$2.08 M (-92.66%)
What is NGM Biopharmaceuticals TTM revenue?
The current TTM revenue of NGM is $4.42 M
What is the all time high TTM revenue for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high TTM revenue is $119.58 M
What is NGM Biopharmaceuticals TTM revenue year-on-year change?
Over the past year, NGM TTM revenue has changed by -$32.22 M (-87.94%)